Kun Ling Ma Selected Research

SREBP cleavage-activating protein

12/2015	Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
12/2013	Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
1/2012	Inflammation disrupts the LDL receptor pathway and accelerates the progression of vascular calcification in ESRD patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun Ling Ma Research Topics

Disease

11	Inflammation (Inflammations) 01/2018 - 01/2012
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 06/2015
5	Atherosclerosis 01/2018 - 10/2013
4	Wounds and Injuries (Trauma) 01/2021 - 01/2014
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2012
3	Non-alcoholic Fatty Liver Disease 01/2018 - 04/2015
2	Proteinuria 01/2019 - 06/2015
2	Hepatoblastoma 01/2018 - 04/2015
2	Necrosis 01/2016 - 01/2012
2	Fibrosis (Cirrhosis) 01/2016 - 01/2013
2	Body Weight (Weight, Body) 01/2014 - 01/2013
1	Chronic Renal Insufficiency 10/2022
1	Insulin Resistance 01/2021
1	Dysbiosis 01/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 06/2019
1	Hypertrophy 03/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Pathologic Processes 01/2017
1	Hyperglycemia 01/2016
1	Retinoblastoma (Glioblastoma, Retinal) 12/2013
1	Vascular Calcification 01/2012

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2018 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2012
6	CholesterolIBA 01/2020 - 01/2013
6	LDL Receptors (LDL Receptor)IBA 01/2018 - 01/2012
5	ApolipoproteinsIBA 01/2018 - 01/2013
4	Caseins (Casein)FDA Link 01/2018 - 12/2013
3	Chemokine CXCL16IBA 01/2018 - 01/2016
3	SREBP cleavage-activating proteinIBA 12/2015 - 01/2012
3	Apolipoproteins E (ApoE)IBA 04/2015 - 01/2013
2	Periodic AcidIBA 01/2021 - 03/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2014
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016 - 01/2012
2	C-Reactive ProteinIBA 01/2016 - 01/2012
2	Sterol Regulatory Element Binding ProteinsIBA 12/2015 - 12/2013
2	CreatinineIBA 06/2015 - 01/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 04/2015 - 10/2013
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2015 - 12/2013
2	Peptide Initiation Factors (Initiation Factor)IBA 04/2015 - 12/2013
2	CollagenIBA 01/2013 - 01/2012
1	Biological ProductsIBA 10/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Thromboplastin (Tissue Factor)IBA 06/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2019
1	anti-dsDNA autoantibodyIBA 01/2019
1	Streptozocin (Streptozotocin)FDA Link 11/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	CXCR ReceptorsIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Lipoprotein(a)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Purinergic P2X7 ReceptorsIBA 01/2016
1	CXCR6 ReceptorsIBA 01/2016
1	Filipin (Filipin III)IBA 10/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2015
1	Hematoxylin (Haematoxylon)IBA 10/2015
1	oil red OIBA 10/2015
1	SubtilisinIBA 04/2015
1	TOR Serine-Threonine KinasesIBA 04/2015
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 04/2015
1	AlbuminsIBA 01/2014
1	nephrinIBA 01/2014
1	LipopolysaccharidesIBA 12/2013
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	oxidized low density lipoproteinIBA 01/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013
1	Alkaline PhosphataseIBA 01/2012

Therapy/Procedure

2	Subcutaneous Injections 04/2015 - 12/2013
1	Transplantation 01/2021